Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 5.17 Million USD | -0.91% |
| 2019 | 5.21 Million USD | 68.61% |
| 2018 | 3.09 Million USD | -11.41% |
| 2017 | 3.49 Million USD | -9.62% |
| 2016 | 3.86 Million USD | 35.27% |
| 2015 | 2.85 Million USD | 0.0% |
| 2012 | 3.28 Million USD | 20.17% |
| 2011 | 2.73 Million USD | 1.42% |
| 2010 | 2.69 Million USD | -11.13% |
| 2009 | 3.03 Million USD | -27.51% |
| 2008 | 4.19 Million USD | 47.37% |
| 2007 | 2.84 Million USD | 9.17% |
| 2006 | 2.6 Million USD | 75.43% |
| 2005 | 1.48 Million USD | 19.28% |
| 2004 | 1.24 Million USD | 85.31% |
| 2003 | 671.67 Thousand USD | 35.39% |
| 2002 | 496.1 Thousand USD | -61.51% |
| 2001 | 1.28 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 5.13 Million USD | -0.67% |
| 2021 Q2 | 5.29 Million USD | 3.05% |
| 2021 Q3 | 5.39 Million USD | 1.95% |
| 2020 Q4 | 5.17 Million USD | -10.68% |
| 2020 FY | 5.17 Million USD | -0.91% |
| 2020 Q2 | 5.33 Million USD | -14.59% |
| 2020 Q3 | 5.78 Million USD | 8.49% |
| 2020 Q1 | 6.24 Million USD | 19.74% |
| 2019 FY | 5.21 Million USD | 68.61% |
| 2019 Q2 | 2.37 Million USD | -28.19% |
| 2019 Q3 | 2.68 Million USD | 13.32% |
| 2019 Q4 | 5.21 Million USD | 94.14% |
| 2019 Q1 | 3.3 Million USD | 15.89% |
| 2018 Q4 | 2.84 Million USD | 0.6% |
| 2018 FY | 3.09 Million USD | -11.41% |
| 2018 Q1 | 2.68 Million USD | -17.28% |
| 2018 Q2 | 2.49 Million USD | -7.09% |
| 2018 Q3 | 2.83 Million USD | 13.47% |
| 2017 Q3 | 3.48 Million USD | 0.0% |
| 2017 Q1 | 3.29 Million USD | -9.11% |
| 2017 FY | 3.49 Million USD | -9.62% |
| 2017 Q4 | 3.24 Million USD | -6.69% |
| 2016 Q1 | 3.86 Million USD | 105.68% |
| 2016 FY | 3.86 Million USD | 35.27% |
| 2016 Q4 | 3.61 Million USD | 6.52% |
| 2016 Q3 | 3.39 Million USD | 11.19% |
| 2016 Q2 | 3.05 Million USD | -21.01% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q4 | 1.88 Million USD | 0.0% |
| 2015 Q1 | 3.44 Million USD | 0.0% |
| 2015 Q2 | 3.42 Million USD | -0.57% |
| 2015 FY | 2.85 Million USD | 0.0% |
| 2013 Q1 | 3.94 Million USD | 19.88% |
| 2013 Q3 | 4.36 Million USD | 3.78% |
| 2013 Q2 | 4.2 Million USD | 6.58% |
| 2012 Q1 | 2.75 Million USD | 0.47% |
| 2012 Q2 | 3.37 Million USD | 22.86% |
| 2012 Q3 | 3.52 Million USD | 4.41% |
| 2012 Q4 | 3.28 Million USD | -6.76% |
| 2012 FY | 3.28 Million USD | 20.17% |
| 2011 Q4 | 2.73 Million USD | -13.58% |
| 2011 Q2 | 2.93 Million USD | 10.42% |
| 2011 FY | 2.73 Million USD | 1.42% |
| 2011 Q1 | 2.65 Million USD | -1.56% |
| 2011 Q3 | 3.16 Million USD | 7.97% |
| 2010 FY | 2.69 Million USD | -11.13% |
| 2010 Q1 | 2.34 Million USD | -22.65% |
| 2010 Q2 | 1.89 Million USD | -19.13% |
| 2010 Q3 | 1.56 Million USD | -17.46% |
| 2010 Q4 | 2.69 Million USD | 72.12% |
| 2009 Q4 | 3.03 Million USD | 3.86% |
| 2009 Q1 | 3.76 Million USD | -10.13% |
| 2009 FY | 3.03 Million USD | -27.51% |
| 2009 Q2 | 3.21 Million USD | -14.58% |
| 2009 Q3 | 2.92 Million USD | -9.07% |
| 2008 FY | 4.19 Million USD | 47.37% |
| 2008 Q1 | 2.82 Million USD | -0.55% |
| 2008 Q2 | 3.02 Million USD | 6.81% |
| 2008 Q3 | 3.26 Million USD | 8.25% |
| 2008 Q4 | 4.19 Million USD | 28.17% |
| 2007 FY | 2.84 Million USD | 9.17% |
| 2007 Q2 | 2.56 Million USD | 4.8% |
| 2007 Q1 | 2.44 Million USD | -5.99% |
| 2007 Q3 | 2.25 Million USD | -12.01% |
| 2007 Q4 | 2.84 Million USD | 25.93% |
| 2006 FY | 2.6 Million USD | 75.43% |
| 2006 Q4 | 2.6 Million USD | -3.69% |
| 2006 Q3 | 2.7 Million USD | 55.2% |
| 2006 Q1 | 1.74 Million USD | 17.8% |
| 2006 Q2 | 1.74 Million USD | -0.36% |
| 2005 Q1 | 1.44 Million USD | 16.25% |
| 2005 Q4 | 1.48 Million USD | 3.95% |
| 2005 Q3 | 1.42 Million USD | 29.83% |
| 2005 Q2 | 1.1 Million USD | -23.97% |
| 2005 FY | 1.48 Million USD | 19.28% |
| 2004 FY | 1.24 Million USD | 85.31% |
| 2004 Q4 | 1.24 Million USD | 63.53% |
| 2004 Q3 | 761.11 Thousand USD | -2.96% |
| 2004 Q2 | 784.36 Thousand USD | -15.52% |
| 2004 Q1 | 928.51 Thousand USD | 38.24% |
| 2003 Q2 | 660.72 Thousand USD | 11.23% |
| 2003 FY | 671.67 Thousand USD | 35.39% |
| 2003 Q4 | 671.67 Thousand USD | 8.62% |
| 2003 Q1 | 594.02 Thousand USD | 19.74% |
| 2003 Q3 | 618.35 Thousand USD | -6.41% |
| 2002 Q2 | 577.57 Thousand USD | -57.98% |
| 2002 Q1 | 1.37 Million USD | 0.0% |
| 2002 FY | 496.1 Thousand USD | -61.51% |
| 2002 Q3 | 495.41 Thousand USD | -14.22% |
| 2002 Q4 | 496.1 Thousand USD | 0.14% |
| 2001 FY | 1.28 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | 100.0% |
| Allstar Health Brands, Inc. | 9.3 Million USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | 100.0% |
| Health Advance Inc. | 543.26 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 86.3 Million USD | 100.0% |
| MedGen, Inc. | 43.63 USD | 100.0% |
| Omni Health, Inc. | 1.94 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | 100.0% |
| Pineapple, Inc. | 10.61 Million USD | 100.0% |
| ScripsAmerica, Inc. | 9.16 Million USD | 100.0% |